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Summary
Adhesion molecules are probably required for retention of maturing lymphocyte precursors in
bone marrow, where they closely interact with and are dependent on stromal cells. Lympho-
myeloid cell lines avidly adhere to cloned stromal cell lines in culture and screening pairs of these
resulted in a selection strategy for a new monoclonal antibody to a leukocyte adhesion molecule.
Immunoprecipitation analyses and comparison to a previously described antibody showed that
it recognizes the a4 chain of the integrin, VLA4. This antibody totally inhibited lymphopoiesis
and retarded myelopoiesis in long-term bone marrow cultures. A similar selection strategy resulted
in two additional antibodies which define a single 100-kD species on stromal cells. This stromal
cell adhesion molecule is a potential counter-receptor/ligand for VLA4 on murine Lmpho-myeloid
cells. Our findings suggest a new role for VLA-4 in lymphoid progenitor-microenvironment
interactions. Recognition molecules that function in cell migration and inflammation in peripheral
tissues may be important for steady-state lymphopoiesis within bone marrow.
apid progress has been made in determining the molec-
ular basis for cell-cell and cell-matrix interactions. A
number ofpotential cell adhesion molecules have been iden-
tified in experimental models of bone marrow, where both
types of interactions are probably essential for the orderly
expansion, movement, and maturationof bloodcell precursors
(1-7). Members ofthe large integrin superfamily of cell adhe-
sion/recognition molecules participate in many vital func-
tions in development, hemostasis, and immune responses.
Little is known about their possible involvement in lympho-
hemopoiesis, but there are reports that erythroid and lym-
phoid precursors express fibronectin receptors (3, 4).
We previously obtained evidence that CD44 can function
as a cell adhesion molecule on certain lymphoid cell lines by
recognition of hyaluronate (8, 9). Antibodies to CD44 in-
hibit production of lymphoid and myeloid cellsin long-term
bone marrow cultures (LTBMC)t, suggesting that this may
be an essential cell interaction molecule. However, we found
that the adhesion ofsome Lmpho-myeloid cell linesto cloned
stromal cells couldnot be explained on the basis of hyaluronate
recognition by CD44 and there was reason to believe that
multiple cell adhesion mechanisms were involved (9, 10). We
have now developed a satisfactory cell adhesion model to ad-
'Abbreviation used in this paper. LTBMC, long-termbone marrow cultures.
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dress this question, and used it to prepare two types of mAbs.
The first, prepared by immunizing with Lmpho-myeloid cells,
recognizes the integrin VLA4. This antibody inhibited
hemopoietic cell-stromal cell recognition and blocked lym-
phopoiesis in long term bone marrow cultures. Two addi-
tional antibodies were prepared by immunizing with adherent
fibroblast-like cells and selection with a similar adhesion assay.
The monomeric glycoprotein they recognize is also an adhe-
sion molecule, but one with a quite different pattern of cel-
lular representation. It is similar in size to human VCAM-1,
which is thought to be a counter-receptor for VLA4 (11).
Thus, VLA4, which is a well defined receptor for extracel-
lularmatrix and cell associated ligands may contribute to lym-
phopoiesis within the bone marrow microenvironment.
Materials and Methods
CellLines.
￿
TheBM-2 Bcell hybridoma and 70Z/3 pre-B lym-
phomalineshave been described(8, 12). TheBlymphoma, WEHI
231, and the P815 mastocytoma lines were obtained through the
American Type CultureCollection (ATCC) (Rockville, MD).The
stromal cell clone +/+ 2.4 was initiallyderived as acontrol from
thebone marrow of normal littermates of WCB6F,/J.Sl/Sla mice
(13). Preliminary experiments established that certain lymphomy-
eloid cell lines bound avidly to it via a mechanism that was un-
related to CD44 (see Table 1). All cell lines were maintained in
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Monoclonal Antibodies and Fibronectin Fragments. Fisher rats
(Sasco, Omaha, NE) were immunized intraperitoneally with P815
forPS/2 or BALB/3T3 and +/+ 2.4 cells forM/K series antibodies .
Spleen cells from these rats were then fusedwith Sp2/0 cells. Hy-
bridoma supernatantswere screened with a cell adhesion assay using
P815 and BALB/3T3 for PS/2 or 70Z/3 and +/+ 2.4 for M/K
series antibodies. Hybridoma cells producing blocking antibodies
werecloned bylimiting dilutionsand reselected by thesame proce-
dure . PS/2 is IgG2b/rc, and M/K-1 andM/K2 are both IgG1/rc .
Control antibodies were KM 201 (IgGI) directed against CD44
(8), FD441.8 (IgG2b) specific for LFA-1 (obtained from ATCC),
14.8 (IgG2b) reactive withCD45R (14), KMC8.8 (IgG2a) directed
against a bone marrow-derived stromal cell clone BMS2 (8), and
R1-2 (IgG2b) recognizing Peyer's patch-specific homing receptor
(15) . All antibodies except R1-2 were semipurified out of ascitic
fluid from SCID mice withABxcolumn chromatography U.T . Baker
Inc., Alexandria, VA) . The culture supernatant from R1-2 wascon-
centrated by ammonium sulfate precipitation . Arabbit serum against
murine fibronectin and 40- and 120-kD fragments from human
fibronectin was purchased from Telios, Inc. (San Diego, CA).
Cell Adhesion Assay .
￿
Cell lines were radiolabeled by incubating
2 x 107 cells/ml in complete medium (10% FCS RPMI 1640)
with 100 ACi of Na21'Cr04 for 1 h at 37°C and then washed
three times in complete medium. The +/+ 2.4 stromal cell clone
was plated in 24-well plates (Coming GlassWorks, Coming, NY)
at 3 x 104 cells/well and allowed to grow overnight before the
adhesion assay. The labeled cells (2 x 10 1/well) were added to the
stromal cell layer and incubated 30 min at 37°C . ,The unbound
cells were removedby three cycles of washing in prewarmedcom-
plete medium with vigorous agitationon aMinishaker (Dynatech
Laboratory Inc., Alexandria, VA) for 30 s before each aspiration .
Bound cells were lysedwith 0.1NNaOH, 1% Triton X-100(Sigma
Chemical Co., St . Louis, MO), and the "Cr was counted with
ay counter (Beckman Instruments Inc., Fullerton, CA). Percen-
tages ofbound cells were determined by the formula : percent bound
= 100x [(cpm from bound cells)/(input cell associated cpm -
spontaneously released cpm)] . Antibodies were added at the same
time as the labeled hemopoietic cells.
LTBMC .
￿
LTBMCof B lineage cells were prepared according
to methods detailed by Whitlock and Witte (16). Briefly, pooled
cells from femora and tibiae were placed into 25-cm2 flasks (6 x
106 cells/culture ; Costar, Cambridge, MA). The culture medium
consisted ofRPMI 1640 (Gibco Laboratories, Grand Island, NY),
2mM glutamine, 100 U/ml penicillin, 100 Ftg/ml streptomycin,
50 AM 2-ME, and5% FCS (Lot no. 1111885 ; Hyclone Laborato-
ries, Logan, UT). LTBMCofmyeloid cells were initiated andmain-
tained by the methods described by Dexter et al . (17) . Briefly, 10'
bone marrow cells were cultured in 25-cm2 flasks . The culture
medium consisted ofot-MEM (Gibco Laboratories), penicillin, strep-
tomycin, 10' M hydrocortisone sodium salt, and 20% horse
serum (Gibco Laboratories) . These flasks were incubated in 5%
C02 at 33°C . In both LTBMC, half of medium (3 ml) was
replaced with freshmedium weekly. The antibodies (3 Ag/ml) were
added to the medium at the beginning of culture and with each
feeding.
CellSurface Biotirrylotion andImmunoprecipitation.
￿
Cells were sur-
face labeled by a sulfosuccinimidobiotin (Sulfo-NHS-biotin) (Pierce
ChemicalCo., Rockford, IL) procedure. Briefly, after three washes
in HBSS), cells were suspended in saline with 0.1 M Hepes, pH
8.0, (10 x 106/ml) . Sulfo-NHS-biotin was dissolved in a small
amount of saline and added to cell suspensions such that the final
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concentration ofNHS-biotin was0.1 mg/ml. After a40-min incu-
bation at room temperature with occasional shaking, cells were
washed three times with chilledRPMI 1640 . The cell lysates were
prepared (5 x 10'/ml) in a lysis buffer containing 50mM Tris-
HCI, 150mM NaCl, 1% Triton X-100, 50 mM iodoacetamide,
2 MM MgC12, 2 MM CaC12, and 0.1% sodium azide. EDTA
(3 mM) was used instead of MgC12 and CaC12 in the experiment
indicated . Soybean trypsin inhibitor (10 ttg/ml), aprotinin (1 U/ml),
PMSF (1 mM), and Leupeptin (1 pg/ml) were added as protease
inhibitors . After centrifugation, the lysates were precleared twice
with 50 P .1 goat anti-rat IgG Sepharose 4B (Zymed Laboratories,
San Francisco,CA)conjugated with normal rat IgG, and then im-
munoprecipitated with amAb-conjugated goat anti-rat IgG Seph-
arose 4B for 2 h at 4°C with rotation . After washing three times
in a buffer containing 50 mM Tris-HCI (pH 8.3), 0.6M NaCl,
0.5% NP-40, and 0.1% sodium azide, the bound proteins were
released by boiling for5 min in asample buffer containing 0.125M
Tris-HCI, 2% SDS, and 10% glycerol with or without 5% 2-ME,
pH 6.8. SDS-PAGE was carried out as in our previous studies (8) .
After electrophoresis, the gels were equilibrated for 30 min in
a transfer buffer (25 mM Tris, 192mM glycine, and 20% meth-
anol) and proteins were electrophoretically blotted onto nitrocel-
lulose membranes (Bio-Rod Laboratories, Richmond, CA) . The
membraneswere soaked for 1hin PBS containing10%BSA,0.05%
Tween 20,and0.1% thimerosal, andfollowed by a60-min incuba-
tion with 0.1% avidin horse radish peroxidase (Bio-Rod Laborato-
ries), 1% BSA, and 0.05% Tween20. After washing in PBS con-
taining0.05% Tween20, biotinylated proteinswere visualized with
PBScontaining 0.6 mg/m14-chloro-l-Naphthol (Sigma Chemical
Co.), 0.003% hydrogen peroxide, and 20% methanol .
Immunofluorescence Analyses.
￿
Cells were incubated for 20 min
on ice with biotinylated PS/2 in RPMI 1640 supplemented with
5%FCSand0.1% sodium azide. This was followed by twowashes
and incubation with fluoresceinated avidin (Zymed Laboratories)
for an additional 20 min . Propidium iodide was added during the
secondincubation to detect dead cells . Labeled cells were then ana-
lyzed on an EPICS V flow cytometer (Coulter Electronics Inc.,
Hialeah, FL). Staining was similar for mAbs that were unlabeled
with biotin except that FITC labeled mouse anti-rat Ig was used
as a second reagent . For crossblocking experiments, cells were prein-
cubated in saturating amountsof unlabeled antibodies for20 min,
washed three times, and then stained with biotinylated antibody.
Results
Derivation ofa NewmAb to VLA-4.
￿
Previous studies sug-
gest that multiple cell adhesion molecules and ligands may
contribute to themutual recognition of lymphocyte precursors
andthe stromal cells that regulate their growth and differen-
tiation (9). Selection of a given pair of stromal cells and
lympho-myeloid cell lines that adhere to each other allows
one or more adhesion molecules/ligands to be individually
studied . For example, the avid binding ofBM-2 hybridoma
cells to the BMS2 stromal line requires CD44 and hyaluronate
(9).We sought a new experimental model in which neither
CD44 or cellboundhyaluronate were important . The results
ofonesuch analysis areshownin Table 1.While 70Z/3 (pre-B
lymphoma), P815 (mastocytoma), andWEHI 231 (B lym-
phoma) cells all displayed measurable affinity for several ad-
herent cell lines, this was resistant to inhibition by the KM201
mAb, which inhibits BM-2 binding (8) . This cell adhesionA bone marrow stromal cell clone, + / + 2.4 (13), was placed in 24-well plates (3 x 104 cells/well) . Radiolabeled cell lines were added 1 d later
with the indicated antibodies (10 pg/ml) and washed out after a 30-min incubation at 37°C. The results are presented as mean percentages of bound
cells ± SE for quadruplicate determinations .
system then formed the basis for development and selection
of two types of mAbs .
The PS/2 antibody was obtained by immunization of rats
with P815 cells . It had a distinctly different pattern of inhibi-
tion from that previously found with anti-CD44 antibodies
(8, 9) (Table 1) . When used with the most ideal pair of ad-
herent and nonadherent cells (P815 and +/+ 2.4 stromal cells),
adhesion was blocked in a dose-dependent manner (Fig. 1) .
The 70Z/3 cell line was slightly less efficient in binding to
this stromal cell clone, but it was similarly sensitive to inhi-
bition by PS/2 (Table 1) .
Cell surface labeling and immunoprecipitation were then
done to characterize the glycoprotein recognized by PS/2 (Fig.
2) . In the presence of divalent cations, and without reduc-
tion, two protein species were observed by SDS-PAGE of ma-
terial from 70Z/3 cells. The small band was lost in the pres-
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Figure 1 .
￿
A new mAb blocks adhesion of lymphomyeloid cells to a
stromal cell clone. An adherent layer was prepared with the +/+ 2.4 stromal
cell clone and S'Cr-labeled P815 cells were added the following day. Tripli-
cateculture wells contained an antibody to LFA1(FD441.8), or PS/2 mAbs.
After 15 or 30 min of incubation and vigorous washing, the fraction of
adhering cells (mean ± SE) was determinedby scintillation counting. Similar
results were obtained in two other experiments with P815 and three ex-
periments with 70Z/3 cells .
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ence ofa chelating agent, EDTA . This indicates that divalent
cations are required for the noncovalent association of two
chains to form a heterodimer. The epitope recognized by PS/2
must reside on the larger of the two chains. Their mobility
was affected by reduction and their approximate molwt were
130 and 150 kD .
The 130-kD band was also detectablewhen P815 cells were
subjected to similar analysis (Fig. 2) . However, with this cell
Figure 2 .
￿
Immunoprecipitation ofsurfacebiotin-labeled material from
70Z/3 and P815 cells with PS/2 mAbs . The lysis buffer contained Triton
X-100 and either divalent cations (lanes 1, 2, and 5-8), orEDTA (lanes
3, 4, 9 and 10) . Antibody-coated beads were used to recover labeled glyco-
proteins which were subsequently run on 7.5% SDS PAGE, transferred
to nitrocellulose, and developed with horseradish perwidase-labeled avidin.
Table 1 .
Cell line
7wo Cell Adhesion Mechanisms
None
Distinguished by mAbs
FD441 .8
mAb added
PS/2 KM 201 14.8
BM-2 62.9 ± 3.2 69.8 ± 3.6 50.8 ± 3.9 7.3 ± 1.1 66.2 ± 2.2
B815 58.8±1 .3 57.1±1.6 16.7±0.5 52.9±0.9 ND
70Z/3 45.5±3.5 48.1±3.6 15.9±3.4 41.1±3.2 47.5±3.3
WEH1231 77 .1 ± 1.6 64.7 ± 0.6 3 .8 ± 0.2 67.6 ± 0.6 66.3 ± 2.3line, the larger species appeared to be more labile, and two
small proteins of 85 and 70 kD were precipitated. Most of
the smallest band was lost together with the 130 kD subunit
when the isolation was done under divalent cation free con-
ditions. Thus, the PS/2 epitope may be on the 85-kD poly-
peptide of P815 cells.
These immunochemical characteristics were very similar
to the recently described murineVLA4 integrin, as detected
by the Rl-2 mAb to the Peyer's Patch homing receptor,
LPAM-1 (15) as well as antibodies to human VLA4 (18) .
Identical sized bands were precipitated from 70Z/3 by R1-2
and PS/2 antibodies (Fig. 3 A) and flow cytometric analysis
was performed to determine if similar epitopes were being
recognized . Thetwo antibodies gave similar, strong positive
staining of 70Z/3, BM-2, WEHI-231, and P815 cells (not
shown). When 70Z/3 cells were pretreated with unlabeled
PS/2 before subsequent staining with biotinylated PS/2, com-
plete blocking was achieved. Almost the same degree of in-
terference was achieved with R1-2, while a control antibody
against CD44 (KM201) had little effect (Fig. 3 B) . There-
fore, epitopes recognized by the PS/2 and R1-2 antibodies
must be closely associated on the a4 chain of VLA-4 . That
the epitopes are not identical is indicatedby the fact that PS/2,
but not R1-2, recognizes human cells (data not shown) .
The antigen(s) recognized by PS/2 was absent or minimally
detectable on stromal cells, whereas virtually all lympho-
myeloid cells were positive. Bonemarrow cells expressed the
highest density (Fig. 4) and, in sections, it appeared to be
concentrated at cell junctions (data not shown) . In contrast
to a previous report that human granulocytes lack VLA-4
Figure 3.
￿
Crossblocking and immunoprecipitation with a previously
characterized antibody to VLA4. (A) 70Z/3 cells were surface labeled
and precipitated with PS/2, Rl-2, or control rat IgG before SDS-PAGE
under reducing conditions . (B) The same cells were also analyzed by flow
cytometry after immunofluorescent labeling with PS/2. The staining in-
tensity achieved with PS/2 without pretreatment is shown in the upper
panel . The lower panel shows theresults obtainedwhenthecells hadbeen
previously treated with unlabeled PS/2, R1-2, or KM 201 antibodies.
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(18), myeloid cells maintained under Dexter-type long-term
bone marrow conditions were positive, as were lymphoid cells
from Whitlock-Witte cultures (Fig. 4) .
Inhibition ofLong-term Cultures byAntibodies to VLA-4.
￿
Ad-
dition ofmAbs to long-term cultures can be used to impli-
cate cell surface glycoproteins in normal bone marrow func-
tions (8) . Whitlock-Witte cultures sustain growth of pre-B
cells in association with an adherent layer (16) . Production
oflymphocytes was completely blocked by inclusion ofPS/2
mAbs in the culture medium (Fig. 5 ; Fig . 6 A and B) . A
slightly different result was obtainedwhen bonemarrow was
placed in culture under Dexter-type conditions, which favor
the growth of myeloid and stem cells (17) . When PS/2 was
present in that circumstance, foci ofsurface adherent myeloid
cells were in-frequent during the first few weeks. However,
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Figure 4 .
￿
Expression of VLA-4 on lymphoid and myeloid cells . Flow
cytometric analysis was performed on lymphoid cells obtained from
Whitlock-Witte type LTBMC or myeloid cells present in fresh marrow
cell suspensions or Dexter cultures. Dark curves represent the immuno-
fluorescence resulting frombiotin-labeled PS/2 antibody followed by treat-
ment with fluorescein-labeled avidin . Light tracings depict background
staining with only the second reagent .
VLA-4 Function in Lympho-hemopoiesis
Fluorescence Intensity
Weeks After Initiation
Figure 5 .
￿
mAbs to VLA-4 block lymphopoiesis inLTBMC. Replicate
cultures ofmurinebone marrowwere prepared and maintained in the con-
tinuous presence ofrat IgG2b antibodies toVLA4 (PS/2), CD45R (14 .8),
or medium alone. Numbers of nonadherent cells collected at weekly in-
tervals were counted by hemacytometer (mean cells per five flasks t SE) .Figure 6.
￿
Effect of mAbs to VLA-4 on the morphology ofLTBMC . Lymphocyte foci developed normally in Whitlock-Witte cultures containing
the control 14.8 antibody (A), but not in the presence of PS/2 (B) . Changes in the adherent stromal cells were not remarkable. Surface adherent myeloid
cells were plentiful in Dexter cultures containing the control antibody to LFA-1 after 3 wk of culture (C). In contrast, hemopoietic cells were mostly
restricted to flattened foci beneath the stromal cell layer in Dexter cultures containing PS/2 (D).
progenitor cells appeared to be present beneath the stromal
cell layer (Fig. 6 C), which eventually generated nonadherent
myeloid cells in normal numbers by 6 wk of culture (Fig .
7) . Therefore, lymphopoiesis was completely sensitive, and
myelopoiesis was retarded, in cultures containing this antibody.
The adherent layers oflong-term cultures seemed unaffected
by PS/2 antibodies (Fig. 6) . In Dexter cultures, the usual com-
plex arrangement of adipocytes, stromal cells, and macrophages
was seen (Fig. 6 C) . Similarly, the antibody had little influence
on most colony assays involving lymphoid and myeloid pro-
genitors (not shown) . These included semisolid agar cultures
with I1r7 (pre-B cell colonies ; CFU-pre-B) andL cell-condi-
tioned medium (CFU-c) . When added to methylcellulose
cultures containing lymphocyteclones over an adherent stromal
cell layer, numbers of proliferating foci were normal. How-
ever, the colonies weremuch more compact than usual (not
shown) . This indicates that the antibodymay induce sponta-
neous cell aggregation or impede lymphocyte migration .
Antibodies to an Adhesion Molecule on Stromal Cells .
￿
Previous
reports suggest that integrins on lymphocyte precursorsmay
function by recognition of fibronectin on microenvironmental
elements (4) . Furthermore, the CS-1/V25 region of fibronectin
is known to be one ligand for VLA4 (19, 20) . However,
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in preliminary experiments, a rabbit antiserum to mouse
fibronectin had no effect on the binding of P815, 70Z/3, or
WEHI 231As to +/+ 2.4 stromal cells. Furthermore, 70Z/3
cells did not have the same avidity for dishes precoated with
40 kDa and 120 kDa human fibronectin fragments as they
did for +/+ 2.4 cells . As previously reported (4), there was
a relatively high background ofbinding to controlBSA treated
wells when serum free medium was used. The weak binding
to fibronectin or BSA was not diminished by the PS/2 anti-
body (results not shown) . These negative results prompted
a search for other possible ligands for the VLA4 expressed
on stromal cell clones .
Rats wereimmunized with BALB/3T3 cells and boosted
a final time with +/+ 2.4 stromal cells to elicit antibodies
to adherent cell antigens. After fusion, hybrids were selected
with a rapid screening assay involving the adherence of 70Z/3
cells to +/+ 2.4 cells . Two antibodies, M/K-1 and M/K-2,
which were effective for blocking this system, were identified
from >1,000 hybrids (Fig . 8) . The inhibitions were substan-
tial with P815,WEHI 231, and 70Z/3 cells, but always slightly
less than those achieved with the PS/2 antiVLA4 antibody.
While staining of +/+ 2.4 stromal cells was detectable by
flow cytometry with thesetwonew antibodies, the lympho-0
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Figure 7 .
￿
mAbs to VLA-4 retard myeloid cell production in Dexter-
type LTBMC. Isotype matched antibodies were added as indicated at the
beginning ofculture andreplenished with each feeding. Numbers ofnonad-
herent cells were enumerated by hemacytometer counts at weekly intervals
(mean of five flasks ± SE) .
None KMC8 .8 PS/2 M/K-1 M/K-2
Monoclonal Antibody Added
Figure 8.
￿
New mAbs to a stromal cell antigen inhibit adhesion ofpre-B
lymphoma cells to a stromal cell clone.A representative experiment is shown
wherechromium labeled 70Z/3 cells were addedto wells containing +/+
2.4 stromal cells in the presence of 10Ftgm/ml ofvarious mAbs . The new
M/K series of antibodies were compared to a previously described anti-
body (KMC8.8) which recognizes stromal cells and myeloid cells (8), along
with the PS/2 antibody to VLA-4 .
myeloid cell lines (70Z/3, P815, andWEHI 231) were nega-
tive (data not shown) . Thus, the M/K-1 and M/K-2 anti-
bodies are directed to an adhesion molecule(s) preferentially
expressed on stromal cells.
Immunoprecipitation of surface labeled material from +/+
2.4 cells with the new antibodies resulted in a single band
of ti100-kD under reducing conditions (Fig . 9) and 92 kD
under nonreducing conditions (results not shown) . No ap-
parent difference was found between these two antibodies,
which appear to recognize a monomeric glycoprotein on
stromal cells . Staining with these reagents was not dimin-
ished by treatment with phosphatidyl inositol-specific phos-
pholipase C (PI-PLC) (data not shown), indicating that the
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Figure 9 .
￿
Immunoprecipitation of a stromal cell surface antigenby new
mAbs . The +/+ 2 .4 stromal cell clone was surface labeled with biotin
and immunoprecipitated with M/K-1, M/K-2 antibodies, or normal rat
IgG and subjected to SDS PAGE under reducing conditions. The single
bands were also observed when nonreducing conditions were used, but
the mobility corresponded to a size of -92 kD (not shown) .
antigen is an integral membrane protein . Additional studies
involving theM/K-1 andM/K-2 antibodies will be described
elsewhere. However, it is important to note here that, in three
independent experiments, both antibodies interfered with the
adhesion oflymphocytes to stromal cells in LTBMC . Moreover,
most of the lymphocytes quickly detached from established
long-term cultures after addition of either the M/K series
or PS/2 antibodies (Miyake et al ., manuscript in preparation) .
Discussion
Transient physical relationships exist between hemopoietic
progenitor cells and the bone marrow microenvironment that
provides signals required for their proliferation and differen-
tiation. Studies with LTBMC indicate that CD44 and hr
aluronate may mediate critical cell interactions in bone marrow,
but that other cell surface glycoproteins and matrix constit-
uents must also be involved (8, 9) . We have now implicated
a second interaction molecule, VLA-4, in B lymphopoiesis
and prepared antibodies that identify a possible counter-
receptor on stromal cells .Any pair of adhesive cells may preferentially utilize only
one of many possible cell adhesion mechanisms. This was
the case with binding ofthe BM2 hybridorna to BMS2 stromal
cells, where CD44 on the former recognized hyaluronate on
the latter (8, 9). Treatment with either hyaluronidase or mAbs
to CD44 virtually eliminated adhesion between these two
cell lines. In contrast, we found that 70Z/3 (pre-B lymphoma),
WEHI-231 (B lymphoma), and P815 (mastocytoma), cell lines
avidly bound to another stromal cell clone, +/+ 2.4. Treat-
ment with anti-CD44, or anti-LFA-1 antibodies had little
effect on binding between these cell lines.
All of the lympho-myeloid cellsused in these experiments
express CD44. Furthermore, BM-2,whose binding was not
inhibited by the PS/2 antibody, is positive for VLA4 when
stained with the same reagent. Thus, various cell lines bind
well to the same stromal cell clone, albeit via different mech-
anisms. The CD44 density on BM-2 cells is high, relative
to the othercells. This could permit it to preferentially bind
hyaluronate, and the very large hyaluronate molecule could
interfere with BM-2 recognition of another stromal cell ligand
with its VLA4. Unlike BM-2, neither 70Z/3 or P815 cells
bound well to hyaluronate coated wells (10). Preferential utili-
zation of one or another cell adhesion molecule could also
result from their selective activation. CD44 and a number
of integrins become functional on lymphocytes after stimu-
lation with phorbol esters or physiologic stimuli (21-25). It
is interesting to consider that developing hemopoietic cells
might selectively modulate the functions of different adhe-
sion molecules as they migrate within and exit from the bone
marrow.
Immunoprecipitation analyses and comparison to the pre-
viously described R1-2 antibody identified the antigen rec-
ognized by PS/2 as the as chain of the VLA-4 integrin het-
erodimer (15). Previous studies revealed that two additional
proteins precipitate with this type of antibody and represent
cleaved fragments from the a4 subunit (15, 18, 19). Further-
more, the presence ofthese small polypeptides may be related
to cell activationstate(26, 27). The two fragments were always
resolved in immunoprecipitates from P815, but not 70Z/3
cells. However, the functional significance is not obvious, be-
cause both cell lines bound well to stromal cells.
All cloned stromal cell lines which support lymphocyte
growth in culture can also make myeloid colony stimulating
factors (reviewed in reference 28). Furthermore, under ap-
propriate culture conditions, the same stromal cells sustain
growth and differentiation of myeloid progenitors (29). This
suggests that some common components ofthe microenviron-
ment are required for support of these distinct lineages of
blood cells. A reciprocal relationship between pre-B cells and
immature myeloid cells in cyclic neutropenia patients (30)
is also consistent with there being common requirements.
However, it is possible to differentially affect these lineages
with culture conditions and other manipulations. For example,
myelopoiesis is preferentially inhibited by low concentrations
of TGF-S whereas the reverse is true with IFN--y (reference
31 and unpublished observations).
The PS/2 antibody completely blocked lymphopoiesis when
added to Whitlock-Witte type cultures, but only retarded
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the outgrowth ofproductivefoci of myeloid cells in Dexter-
type cultures. Bright and dull staining populations of PS/2-
positive myeloid cells were observed by flow cytometry of
normal Dexter cultures (Fig. 4). Lymphocytes taken from
Whitlock-Witte cultures had an apparent density ofVLA4
equivalent to, or less than, that on myeloid cells. Therefore,
the differential effect can not be explained by the absence of
VLA4 on myeloid cells. Further studies might reveal that
early lymphoid and myeloid precursors from which the cul-
tures derive differ in expression or use of VLA-4.
From studies largely done with human VLA4, two poten-
tial ligand/counter-receptors have been described, fibronectin
and VCAM-1. This integrin recognizes the CS-1/V25 do-
main of fibronectin (19, 20, 32) and a possible connection
with lymphopoiesis is suggested by the finding that some
murine pre-B cell lines and bone marrow B lineage cells bound
to plates coated with a similar fibronectin fragment (4). Our
experiments do not eliminate the possibility that lympho-
cytes adhere to the matrix partly through this mechanism.
However, the apparent affinity of hemopoietic cells to fibro-
nectin seemed too weak to explain the binding to stromal
cell lines and this led to a search for other possible ligands
on adherent cells. A similar selection strategy to that used
to obtain the PS/2 antibodyresulted in two additional mAbs
(M/K-1 and M/K2) which recognized a monomeric glyco-
protein on stromal cells, but not on several lympho-myeloid
cell lines. Since both PS/2 and M/K series antibodies inhibited
adhesion in the same system, it is possible that the latter recog-
nize a counter-receptor for VLA-4. However, formal proof
would require molecular definition and manipulation of the
100-kD species precipitated by M/K1 and M/K-2.
A second ligand for VLA4 is inducible on inflamed human
endothelial cells and designated VCAM-1 or INCAM-110 (11,
33-35). There is evidence this molecule is utilized for adhe-
sion of leukocytes and it has been speculated to be involved
in leukocyte extravasation or tumor metastasis, as well as reten-
tion of lymphocytes in germinal centers (36). The murine
counterpart of VCAM-1 has not yet been defined and ex-
pression of VCAM-1 in human bone marrow has not been
studied (37). Furthermore, there have been no formal descrip-
tions of a human long-term culture system comparable to
the one used here to study murine lymphopoiesis. The
similarity in size between human VCAM-1 and the antigen
detected by our M/K series antibodies is interesting and the
possibility of a relationship between the two is under inves-
tigation. Thus far, we know that the antigen is expressed
on one cultured endothelial cell line, where it can function
as a lymphocyte adhesion molecule. Like VLA4, it is easily
detected in murine bone marrow sections, but present on only
a subpopulation of large cells in bone marrow suspensions
(Miyake et al., manuscript in preparation).
Kina et al. (38) prepared a polyclonal antibody to a thymus
derived stromal cell clone, which also blocks adhesion of par-
ticular cell linesto stromal cells. Immunoprecipitation revealed
that the same or closely related molecules are detected by the
polyclonal and M/K series antibodies. This raises the in-
teresting possibility that maturing thymocytesmay use similar
mechanisms for recognition of the mirroenvironment.VLA-4 is the second cell adhesion molecule shown to be
important forlymphopoiesis in long term culture experiments
(8). However, whileantibodies to CD44/Pgp-1 were equally
effective at inhibiting lymphoid and nonlymphoid cultures,
theanti VLA4 antibody studiedhere preferentially inhibited
lymphopoiesis. The antibodies also differ with respect to their
effects when added to previously established cultures. In that
circumstance, lymphocyte deadhesion resulted from addition
References
of PS/2, or M/Kseries, but not anti-CD44 antibodies (Miyake
et al., manuscript in preparation). Exploitation of these ex-
perimental models should allowfurther dissection ofcritical
cell recognition events in lymphopoieticmicroenvironments.
Some of the most important adhesion molecules maybe ones
also required in extramedullary sites for leukocyte migration
and responses to inflammation.
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